This information was published on 2026-08-24T10:41:39 for IP Right Registration Published.
| Field | Value |
| (210) | 2657219 (IR 1919256) |
| (220) |
29 Apr 2026
|
| (300) |
US, 30 Oct 2025, 99471634
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment and prevention of achondroplasia and hypochondroplasia. |
| (540) | LYFIGLO |
| (550) | Word |
| (730) |
Bridgebio Pharma, Inc.
|
Find out more about publications on the About page.